section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

Renal Impairment

US Brand Names

Biaxin XL

Action

  • Inhibits protein synthesis at the level of the 50S bacterial ribosome.
Therapeutic effects:
  • Bacteriostatic action.

Spectrum:

Classifications

Therapeutic Classification: agents for atypical mycobacterium, anti-infectives, antiulcer agents

Pharmacologic Classification: macrolides

Pharmacokinetics

Absorption: Rapidly absorbed (50%) after oral administration.

Distribution: Widely distributed; tissue levels may exceed those in serum.

Protein Binding: 65–70%.

Metabolism/Excretion: 10–15% converted by the liver to 14-hydroxyclarithromycin, which has anti-infective activity; 20–30% excreted unchanged in urine. Metabolized by and also inhibits the CYP3A enzyme system.

Half-Life: Dose-dependent and prolonged with renal dysfunction 250-mg dose: 3–4 hr; 500-mg dose: 5–7 hr.

Canadian Brand Names

Biaxin

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown2 hr12 hr
PO-XLunknown4 hr24 hr

Patient/Family Teaching

Pronunciation

kla-RITH-roe-mye-sin

Code

NDC Code